Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study

Autor: M. Laguno, M.A. Von Wichmann, E. Van den Eynde, J. Navarro, C. Cifuentes, J. Murillas, S. Veloso, M. Martínez-Rebollar, J.M. Guardiola, A. Jou, J.L. Gómez-Sirvent, M. Cervantes, J.A. Pineda, S. López-Calvo, A. Carrero, M.L. Montes, E. Deig, A. Tapiz, J.D. Ruiz-Mesa, A. Cruceta, E. de Lazzari, J. Mallolas

Publikováno v: International Journal of Infectious Diseases, Vol 53, Iss C, Pp 46-51 (2016)

Introduction: Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of BOC + pegylated interferon-α2a/ribavirin (PEG-IFN/RBV) in the retreatment of

Externí odkaz: https://doaj.org/article/05b17d5d28db44e8ba709ee912443059

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

Autor: Watcharapong Mitsuwan, Irene Jiménez-Munguía, Monton Visutthi, Wipawadee Sianglum, Manuel J. Rodríguez-Ortega, Supayang P. Voravuthikunchai, A. Jover, F. Barcenilla, M. García, M. Pujol, O. Gasch, M.A. Domínguez, M. Camoez, C. Dueñas, E. Ojeda, J.A. Martínez, F. Marco, F. Chaves, M. Lagarde, F. López-Medrano, J.M. Montejo, E. Bereciertua, J.L. Hernández, M.Á. von Wichmann, A. Goenaga, J.M. García-Arenzana, B. Padilla, C. Padilla, E. Cercenado, G. García-Prado, J. Tapiol, J.P. Horcajada, M. Montero, M. Salvadó, A. Arnáiz, C. Fernández, E. Calbo, M. Xercavins, A. Granados, D. Fontanals, V. Pintado, E. Loza, J. Torre-Cisneros, R. Lara, F. Rodríguez-López, C. Natera, J.R. Blanco, I. Olarte, N. Benito, B. Mirelis, J. Murillas, E. Ruiz de Gopegui, H. Espejo, M.A. Morera, J. Rodríguez-Baño, L.E. López-Cortés, A. Pascual, C. Martín, J.A. Lepe, J. Molina, R. Sordé, B. Almirante, N. Larrosa

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
MICROBIAL PATHOGENESIS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

REIPI/GEIH Study Group.
Sigma factor B (SigB) controls the expression of Staphylococcus aureus genes including virulence factors and plays a role in the bacterial secretion system through membrane vesicle production. Inhibition of SigB could att

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bffd030238c921ec075fa351dcb3456
https://doi.org/10.1016/j.micpath.2018.12.019

Analysis of the disease burden of influenza in the last five seasons (2013-2018)

Autor: J, Reina, P, Fraile, J, Murillas

Publikováno v: Revista clinica espanola. 219(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::427db93fb6dfe81917ab3602eda92119
https://pubmed.ncbi.nlm.nih.gov/31109686

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.